Why do heart attacks hit women differently? new study aims to find out

NCT ID NCT06441942

Recruiting now Knowledge-focused Sponsor: IRCCS San Raffaele Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a registry of 100 women who have had a heart attack or unstable angina. Researchers will collect genetic, biochemical, and molecular data to understand how symptoms and disease patterns may vary among women. The goal is to identify subtypes of heart disease that could lead to better, more personalized treatments for women.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could reveal why heart attacks affect women differently and point toward more personalized treatments.
What could go wrong: This is an observational registry, not a treatment trial. It may not lead to immediate changes in care, and results may take years to influence practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome Coitus inherited disease susceptibility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CORONARY SYNDROME GENDER GENETIC PREDISPOSITION

Contacts and locations

Locations

Azienda Ospedaliera Universitaria Federico II
RECRUITING

Naples, Napoli, 80131, Italy
Centro Cardiologico Monzino
RECRUITING

Milan, Milano, 20138, Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
RECRUITING

Milan, Milan, 20122, Italy
IRCCS San Raffaele Hospital
RECRUITING

Milan, Italy Milan, 20132, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.